2022. Estimating the budget impact of innovative pharmacological treatments for patients with type 2 diabetes mellitus in Italy: the case of liraglutide (GLP-1). . Epidemiology, Biostatistics, and Public Health. 12, 2 (May 2022). DOI:https://doi.org/10.2427/11082.